Pilot Study of a 12-Week Exergaming Program to Improve Activity, Sleep, and Well-being in People With Major Neurocognitive Disorders in Long-Term Care

What this Trial Is About

Researchers are evaluating the effects of a 12-week exergaming training program in people with major neurocognitive disorders MNCD living in long-term care facilities. This pilot randomized controlled trial aims to understand how exergaming impacts gait speed, cognitive and motor functions, depressive symptoms, quality of life, physical activity, and sleep in these residents. The study focuses on non-drug therapies combining physical exercise and cognitive stimulation, addressing a public health priority where no current treatments can halt disease progression. Participants will either engage in an active dance video game using the Dividat Senso platform for 15 minutes, three times a week, over 12 weeks or receive usual care consisting of standard activities and customized support. The exergaming involves stepping on directional arrows guided by a large screen with auditory, visual, and sensory feedback. Usual care includes meal services and various social and physical activities. The trial compares these two groups to assess the interventions impact. During the study, researchers will measure physical performance using the Short Physical Performance Battery and cognitive function with the Montreal Cognitive Assessment, among other scales assessing depression, neuropsychiatric symptoms, sleep quality, daily living activities, and quality of life. Physical activity and sleep will be monitored with motion and contactless sensors. Assessments occur at the start and after 12 weeks. Statistical analysis will evaluate changes between baseline and post-intervention outcomes, with safety and efficacy monitored throughout the trial period.

Exergaming Revolution in Dementia